Badgley, Phelps & Bell’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-3,087
Closed -$505K 201
2017
Q4
$505K Sell
3,087
-38,242
-93% -$6.86M 0.03% 141
2017
Q3
$8.47M Buy
41,329
+244
+0.6% +$56.7K 0.63% 74
2017
Q2
$9.99M Buy
41,085
+341
+0.8% +$80.1K 0.78% 50
2017
Q1
$9.73M Buy
40,744
+2,587
+7% +$602K 0.79% 47
2016
Q4
$8.01M Sell
38,157
-2,935
-7% -$608K 0.7% 66
2016
Q3
$9.46M Sell
41,092
-260
-0.6% -$63.5K 0.83% 40
2016
Q2
$9.56M Buy
41,352
+495
+1% +$114K 0.87% 37
2016
Q1
$11M Buy
40,857
+1,611
+4% +$461K 1.03% 29
2015
Q4
$12.3M Buy
39,246
+730
+2% +$217K 1.21% 19
2015
Q3
$10.5M Buy
38,516
+6
+0% +$1.84K 1.09% 26
2015
Q2
$11.7M Sell
38,510
-528
-1% -$157K 1.14% 22
2015
Q1
$11.6M Sell
39,038
-20,611
-35% -$5.88M 1.14% 23
2014
Q4
$15.4M Sell
59,649
-1,677
-3% -$419K 1.5% 7
2014
Q3
$14.8M Buy
61,326
+2,427
+4% +$543K 1.47% 7
2014
Q2
$13.1M Sell
58,899
-1,207
-2% -$250K 1.31% 14
2014
Q1
$12.4M Sell
60,106
-24,387
-29% -$4.83M 1.28% 17
2013
Q4
$14.2M Sell
84,493
-121
-0.1% -$18.9K 1.49% 9
2013
Q3
$12.2M Sell
84,614
-332
-0.4% -$44.2K 1.37% 12
2013
Q2
$10.7M Buy
+84,946
New +$9.62M 1.26% 13

Other funds holding AGN

Badgley, Phelps & Bell's AGN Position: Q1 2018 in Review

Badgley, Phelps & Bell sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 3,087 shares — an estimated $505K sold.

Badgley, Phelps & Bell first reported a position in AGN in Q2 2013 and held it in 19 quarters. The position peaked at $15.4M in Q4 2014. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Badgley, Phelps & Bell reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Badgley, Phelps & Bell sold 3,087 Allergan plc shares in Q1 2018, an estimated $505K.
  • Badgley, Phelps & Bell first reported a position in Allergan plc in Q2 2013 and held it in 19 quarters.
  • Badgley, Phelps & Bell's Allergan plc position peaked at $15.4M in Q4 2014.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Badgley, Phelps & Bell's 13F filing for Q1 2018, filed 8 May 2018.